200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 557-08-4
557-08-4 | Zinc Undecylenate
CAS No: 557-08-4 Catalog No: AG003VEF MDL No:MFCD00067246
Product Description
Catalog Number:
AG003VEF
Chemical Name:
Zinc Undecylenate
CAS Number:
557-08-4
Molecular Formula:
C22H38O4Zn
Molecular Weight:
431.9147
MDL Number:
MFCD00067246
IUPAC Name:
zinc;undec-10-enoate
InChI:
InChI=1S/2C11H20O2.Zn/c2*1-2-3-4-5-6-7-8-9-10-11(12)13;/h2*2H,1,3-10H2,(H,12,13);/q;;+2/p-2
InChI Key:
YMCOHQVWOBMDCZ-UHFFFAOYSA-L
SMILES:
CCCCCCCCC=CC(=O)[O-].CCCCCCCCC=CC(=O)[O-].[Zn+2]
EC Number:
209-155-0
UNII:
388VZ25DUR
NSC Number:
759140
Properties
Complexity:
136
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
3
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
430.206g/mol
Formal Charge:
0
Heavy Atom Count:
27
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
431.922g/mol
Monoisotopic Mass:
430.206g/mol
Rotatable Bond Count:
16
Topological Polar Surface Area:
80.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| A randomised controlled trial of active chronic otitis media comparing courses of eardrops versus one-off topical treatments suitable for primary, secondary and tertiary healthcare settings. | Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 20120801 |
| Nonplanar property study of antifungal agent tolnaftate-spectroscopic approach. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110901 |
| Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo. | Acta poloniae pharmaceutica 20110101 |
| Identification of Hedgehog signaling inhibitors with relevant human exposure by small molecule screening. | Toxicology in vitro : an international journal published in association with BIBRA 20100801 |
| Current concepts in systemic and topical therapy for superficial mycoses. | Clinics in dermatology 20100304 |
| Assay of tolnaftate in human skin samples after in vitro penetration studies using high performance liquid chromatography. | Acta poloniae pharmaceutica 20100101 |
| Study on the supramolecular multirecognition mechanism of beta-naphthol/beta-cyclodextrin/anionic surfactant in a tolnaftate hydrolysis system. | The journal of physical chemistry. B 20060504 |
| Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates. | Medical mycology 20041201 |
| Tolnaftate spray treatment during pregnancy. | Reproductive toxicology (Elmsford, N.Y.) 20040501 |
| Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects. | Journal of veterinary pharmacology and therapeutics 20030201 |
| X-ray powder diffractometric method for quantitation of crystalline drug in microparticulate systems. I. Microspheres. | Journal of pharmaceutical sciences 20020401 |
| [Therapeutic efficacy of a topical tolnaftate preparation in guinea pig model of tinea pedis]. | The Japanese journal of antibiotics 20010601 |
| Two mechanisms of butenafine action in Candida albicans. | Antimicrobial agents and chemotherapy 19930401 |
| Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate. | Antimicrobial agents and chemotherapy 19860501 |
| In vitro activity of naftifine, a new antifungal agent. | Antimicrobial agents and chemotherapy 19810301 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.